focus -WSS

focus

author：leisure time 2025-08-28 03:35:21 - browse：1

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Amazon on where the company's health care bets are headed next

WSS

Are infertility treatments 'essential' during the Covid

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

ALS advocates say criticism of new drugs misses bigger picture

ALS advocates say criticism of new drugs misses bigger picture

Are infertility treatments 'essential' during the Covid

knowledge

focus

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Virginia high school admissions case could be legal follow

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Anesthesiologist group: stop taking Ozempic before surgery

Delta passengers in Vegas fall sick while waiting on flight in triple

Trump demands the U.S. pay no more for drugs than other countries … again

ALS advocates say criticism of new drugs misses bigger picture

After affirmative action ruling, medical educators look to 'holistic review'

Weighted lottery helped low

knowledge

A new House health package & hospitals’ new site

Stanford president’s abrupt resignation sparks debate

Hormonal contraceptives don’t actually treat endometriosis

There’s a way to spot data fakery. All journals should be using it

ALS advocates say criticism of new drugs misses bigger picture

Caribou posts encouraging results on off

Wikipedia

explore

Wikipedia

focus